Department of Neurology, Medical Center of the Ludwig-Maximilians-University of Munich (LMU), Germany; Center of Mental Health, Klinikum Ingolstadt, Germany; Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, Medical Faculty, University of Freiburg, Germany; Center of Parkinsonism and Movement Disorders, Paracelsus-Elena Hospital, Kassel, Germany and Department of Neurosurgery, University Medical Center Göttingen, Germany; Specialized Clinic for Therapies in Neurology, Medical Park Reithofpark, Bad Feilnbach, Germany.
Dtsch Arztebl Int. 2019 Oct 11;116(41):681-688. doi: 10.3238/arztebl.2019.0681.
Sleep-related disorders are a group of illnesses with marked effects on patients' quality of life and functional ability. Their diagnosis and treatment is a matter of common interest to multiple medical disciplines.
This review is based on relevant publications retrieved by a selective search in PubMed (Medline) and on the guide- lines of the German Society for Sleep Medicine, the German Neurological Society, and the German Association for Psychiatry, Psychotherapy and Psychosomatics.
A pragmatic classification of sleep disorders by their three chief complaints-insomnia, daytime somnolence, and sleep-associated motor phenomena-enables tentative diagnoses that are often highly accurate. Some of these disorders can be treated by primary care physicians, while others call for referral to a neurologist or psychiatrist with special experience in sleep medicine. For patients suffering from insomnia as a primary sleep disorder, rather than a symptom of another disease, meta-analyses have shown the efficacy of cognitive behavioral therapy, with high average effect sizes. These patients, like those suffering from secondary sleep disorders, can also benefit from drug treatment for a limited time. Studies have shown marked improvement of sleep latency and sleep duration from short-term treatment with benzodiazepines and Z-drugs (non- benzodiazepine agonists such as zolpidem and zopiclone), but not without a risk of tolerance and dependence. For sleep disorders with the other two main manifestations, specific drug therapy has been found to be beneficial.
Sleep disorders in neurology and psychiatry are a heterogeneous group of disorders with diverse manifestations. Their proper diagnosis and treatment can help prevent secondary diseases and the worsening of concomitant conditions. Care structures for the treatment of sleep disorders should be further developed.
睡眠相关障碍是一组对患者生活质量和功能能力有显著影响的疾病。其诊断和治疗是多个医学学科共同关注的问题。
本综述基于在 PubMed(Medline)中进行选择性检索获得的相关出版物,以及德国睡眠医学学会、德国神经病学会和德国精神病学、心理治疗和身心医学学会的指南。
根据主要抱怨(失眠、白天嗜睡和睡眠相关运动现象)对睡眠障碍进行实用分类,可以做出初步诊断,这些诊断通常非常准确。其中一些障碍可以由初级保健医生治疗,而其他障碍则需要转介给具有睡眠医学专业经验的神经病学家或精神科医生。对于因原发性睡眠障碍而非其他疾病而出现失眠的患者,荟萃分析表明认知行为疗法的疗效,其平均效应量较高。这些患者与因继发性睡眠障碍而出现失眠的患者一样,也可以在有限的时间内受益于药物治疗。研究表明,短期使用苯二氮䓬类药物和 Z 类药物(非苯二氮䓬类激动剂,如唑吡坦和佐匹克隆)可以显著改善睡眠潜伏期和睡眠时间,但存在耐受和依赖的风险。对于具有其他两种主要表现的睡眠障碍,已经发现特定的药物治疗是有益的。
神经病学和精神病学中的睡眠障碍是一组具有不同表现的异质性疾病。正确诊断和治疗可以预防继发性疾病和伴发疾病的恶化。应进一步发展治疗睡眠障碍的护理结构。